Xarelto 20 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FA22D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,845
Award facts
- Contract value 100% obligated
- $16,844.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,844.71 to AmerisourceBergen Drug Corp for the supply of Xarelto 20 mg tablets (90-count units) on October 29, 2025, with completion targeted for October 30, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order to be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for the military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's history of competitively awarded, firm fixed price delivery orders with the DLA Medical Supply Chain demonstrates its capability to efficiently fulfill federal procurement requirements across multiple therapeutic domains. This specific delivery order for Xarelto, an anticoagulant medication, reflects the company's ongoing role in supplying essential pharmaceutical products to support Defense Health Agency operations and other federal healthcare programs.
Quick answers
Who was awarded contract SPE2DB26FA22D?
SPE2DB26FA22D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FA22D worth?
The government has obligated $16,845 on SPE2DB26FA22D.
Is contract SPE2DB26FA22D an order under another contract?
Yes. SPE2DB26FA22D is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB26FA22D competed?
The extent of competition for SPE2DB26FA22D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award